IS4491A

Interferon conjugates

Abstract

Physiologically active PEG-IFN alpha conjugates having a formula as follows: <CHEM>

Term

Term ended

Projected expiry passed 30 May 2017, 9.3 years ago.

83 members in 50 offices

This recordMember, by publication datePriority claim40 more offices are in the list below

Priority claims3

Priority claims
Document	Office	Kind	Date
1883496	United States of America	P	1996-05-31
1883496	United States of America	P	1996-05-31
US19960018834P	–	–	–

Members83

Family members, oldest first
Document	Office	Kind
NO972480D0	Norway	D0	1997-05-30
HU9700959D0	Hungary	D0	1997-07-28
IL120902D0	Israel	D0	1997-09-30
MX9704012A	Mexico	A	1997-11-29
CA2203480A1	Canada	A1	1997-11-30
IS4491AThis record	Iceland	A	1997-12-01
NO972480L	Norway	L	1997-12-01
EP0809996A2	European Patent Office (EPO)	A2	1997-12-03
AU2372397A	Australia	A	1997-12-04
PL320251A1	Poland	A1	1997-12-08
KR970074791A	Republic of Korea	A	1997-12-10
SK67397A3	Slovakia	A3	1997-12-10
CN1167777A	China	A	1997-12-17
CZ167997A3	Czechia	A3	1997-12-17
TR199700358A2	Türkiye	A2	1997-12-21
TR199700358A3	Türkiye	A3	1997-12-21
MA24193A1	Morocco	A1	1997-12-31
GR970300063T1	Greece	T1	1998-01-30
ES2110386T1	Spain	T1	1998-02-16
BG101540A	Bulgaria	A	1998-02-27
HU9700959A2	Hungary	A2	1998-03-02
HUP9700959A2	Hungary	A2	1998-03-02
JPH1067800A	Japan	A	1998-03-10
HU9700959A3	Hungary	A3	1998-03-30
HUP9700959A3	Hungary	A3	1998-03-30
DE809996T1	Germany	T1	1998-04-09
HRP970298A2	Croatia	A2	1998-04-30
SV1997000049A	El Salvador	A	1998-07-09
BR9703421A	Brazil	A	1998-09-15
NZ314903A	New Zealand	A	1998-10-28
ZA974583B	South Africa	B	1998-11-17
SG55314A1	Singapore	A1	1998-12-21
TJ97000465A	Tajikistan	A	1998-12-25
HK1005225A1	Hong Kong, China	A1	1998-12-31
EP0809996A3	European Patent Office (EPO)	A3	1999-04-14
YU17597A	Yugoslavia, later Serbia and Montenegro (until 2006)	A	1999-07-28
BG62273B1	Bulgaria	B1	1999-07-30
JP2980569B2	Japan	B2	1999-11-22
AR008378A1	Argentina	A1	2000-01-19
KR100254097B1	Republic of Korea	B1	2000-05-01
PA8431001A1	Panama	A1	2000-05-24
CO4950528A1	Colombia	A1	2000-09-01
AU725195B2	Australia	B2	2000-10-05
UY24572A1	Uruguay	A1	2000-12-29
TJ328B	Tajikistan	B	2001-12-24
RU2180595C2	Russian Federation	C2	2002-03-20
OA10488A	African Intellectual Property Organization (OAPI)	A	2002-04-11
CN1088721C	China	C	2002-08-07
TW517067B	Taiwan Province of China	B	2003-01-11
EP0809996B1	European Patent Office (EPO)	B1	2003-04-02
AT235920T	Austria	T	2003-04-15
ATE235920T1	Austria	T1	2003-04-15
DE69720320D1	Germany	D1	2003-05-08
UA56989C2	Ukraine	C2	2003-06-16
PT809996E	Portugal	E	2003-06-30
NL300127I1	Netherlands (Kingdom of the)	I1	2003-07-01
DK0809996T3	Denmark	T3	2003-07-21
HRP970298B1	Croatia	B1	2003-08-31
SI0809996T1	Slovenia	T1	2003-08-31
NL300127I2	Netherlands (Kingdom of the)	I2	2003-09-01
ES2110386T3	Spain	T3	2003-10-01
DE10399018I1	Germany	I1	2003-10-23
CZ292775B6	Czechia	B6	2003-12-17
LU91029I2	Luxembourg	I2	2004-01-23
US2004030101A1	United States of America	A1	2004-02-12
PL186949B1	Poland	B1	2004-04-30
DE69720320T2	Germany	T2	2004-06-03
IL120902A	Israel	A	2004-06-20
MY117909A	Malaysia	A	2004-08-30
CY2433B1	Cyprus	B1	2004-11-12
IS1988B	Iceland	B	2005-02-15
TNSN97091A1	Tunisia	A1	2005-03-15
SK284458B6	Slovakia	B6	2005-04-01
SA466B1	Saudi Arabia	B1	2005-11-12
SA97180030B1	Saudi Arabia	B1	2005-11-12
RS49533B	Serbia	B	2006-12-15
NO322964B1	Norway	B1	2006-12-18
US7201897B2	United States of America	B2	2007-04-10
EG24292A	Egypt	A	2009-01-08
CA2203480C	Canada	C	2009-06-30
CY2005006I1	Cyprus	I1	2009-11-04
CY2005006I2	Cyprus	I2	2009-11-04
HU227992B1	Hungary	B1	2012-08-28

Interferon conjugates

Abstract

Term

Priority claims3

Members83

Numbers

Titles2

Classification